Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac and Lidocaine IANB for Irreversible Pulpitis
NCT03410212Phase 2Completed
- Sponsor
- Islamic Azad University, Tehran Medical Sciences Branch
- Start
- Feb 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac in irreversible pulpitis, sponsored by Islamic Azad University, Tehran Medical Sciences Branch. Started Feb 2018; status: completed.
02
Drugs
ketorolac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT03410212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410212.